Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

10.36
BATS BZX Real-Time Price
As of 10:25am ET
 +0.16 / +1.57%
Today’s Change
5.69
Today|||52-Week Range
13.84
-8.32%
Year-to-Date

Today’s Trading

Previous close10.20
Today’s open10.22
Day’s range10.08 - 10.35
Volume52,603
Average volume (3 months)1,203,627
Market cap$1.1B
Dividend yield--
Data as of 10:10am ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)+39.39%
Earnings growth (this year)-40.62%
Earnings growth (next 5 years)+5.61%
Revenue growth (last year)+115.03%
P/E ratioNM
Price/Sales11.48
Price/Book--

Competitors

 Today’s
change
Today’s
% change
HRTXHeron Therapeutics I...+0.55+1.74%
RPTPRaptor Pharmaceutica...+0.14+0.99%
RGENRepligen Corp+0.74+2.12%
CLLSCellectis SA+1.26+3.66%
Data as of 10:25am ET, 07/31/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)-$0.30
Annual revenue (last year)$102.8M
Annual profit (last year)-$83.3M
Net profit margin-81.06%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert J. Mulroy
Head-
Corporate Operations
William M. McClements
Corporate headquarters
Cambridge, Massachusetts

Forecasts